摘要
化疗是肿瘤综合治疗的主要方式之一，多年来在肿瘤治疗中发挥着重要作用。但近年来低剂量化疗以其利用化疗药物的新靶点、采取合理的给药方式和计划，且相对于最大耐受量化疗具有毒副反应小、患者耐受性明显提高、疗效更佳等优势，已逐渐成为肺癌治疗研究的热点和新策略。本文就低剂量化疗的起源、作用机制、优势及存在问题等方面的研究进展作～综述。
Chemotherapy is one of the main ways of comprehensive treatment of tumor,and it has played an important role in the treatment of tumor for many years. In recent years, low-dose chemotherapy has been a hot research and new strategy in the treatment of lung cancer, because it uses new target of chemotherapy drugs, takes reasonable manner of administration and plan, and has fewer toxic side effects, higher patient tolerance and better therapeutic effect compared with the maximum tolerated dose chemotherapy. This article reviews the research progress on the origin, mechanism, predominance and problems of low-dose chemotherapy.
出处
《国际呼吸杂志》
2010年第10期626-630,共5页
International Journal of Respiration
关键词
化疗
低剂量
肿瘤
肺癌
Chemotherapy
Low-dose
Tumor
Lung cancer
